A kind of livestock and poultry immune enhancer bursa polypeptide
An immune enhancer and bursal polypeptide technology, which is applied in the field of livestock and poultry immune enhancer bursal polypeptide, can solve the problems of high cost, no effective vaccine prevention and control of infectious diseases, and reduced vaccine protection.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] ——BP14 as an immune enhancer for recombinant avian influenza virus inactivated vaccine (H5N1 subtype, Re-6 strain)
[0030] 1. Synthetic BP14
[0031] Entrust commercial peptide synthesis company according to COOH-G-H-K-T-R-N-D-P-L-K-G-A-V-D-NH 2 The amino acid sequence (sequence 1) synthesizes the polypeptide, and the purity is required to be ≥ 95%.
[0032] 2. Vaccines
[0033] The recombinant avian influenza virus inactivated vaccine (H5N1 subtype, Re-6 strain) is a commercial vaccine (manufacturer: Guangdong Yongshun Biopharmaceutical Co., Ltd., batch number: 2013037).
[0034] 3. Grouping of experimental animals
[0035] 40 SPF chickens were randomly divided into four groups, 10 in each group: (1) Recombinant avian influenza virus inactivated vaccine (H5N1 subtype, Re-6 strain) immunization group (each bird immunized with inactivated vaccine 1 part / 0.25 ml); (2) Inactivated vaccine + BP14 group (prepared aseptically according to the ratio of inactivated vaccine...
Embodiment 2
[0044] The polypeptide described in the present invention may also be a plurality of concatemers of the polypeptide described in Example 1, such as
[0045] COOH-G-H-K-T-R-N-D-P-L-K-G-A-V-D-G-H-K-T-R-N-D-P-L-K-G-A-V-D-NH 2 and (sequence 2)
[0046] COOH-G-H-K-T-R-N-D-P-L-K-G-A-V-D-G-H-K-T-R-N-D-P-L-K-G-A-V-D-G-H-K-T-R-N-D-P-L-K-G-A-V-D-NH 2 (Sequence 3).
Embodiment 3
[0048] In the vaccine production process of the livestock and poultry immune enhancer BP14 according to the present invention, according to the content of BP14 in the final product of the vaccine is 0.1 μg / feather ratio, it is added to the poultry vaccine antigen liquid and then formulated into a water phase, and then conventionally Mixed with oil phase to emulsify into poultry vaccine.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com